Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer

E-ISSN： 1873-4286|23|32|4745-4757

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.32, 2017-12, pp. : 4745-4757

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor

By Omar Aadilah Jovanovic Katarina Da Costa Dias Bianca Gonsalves Danielle Moodley Kiashanee Caveney Robert Mbazima Vusi Weiss Stefan FT

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments in Potential Anxiolytic Agents Targeting GABAA/BzR Complex or the Translocator Protein (18kDa) (TSPO)

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-02 ,pp. : 360-370

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Cancer Therapy: An Overview

Current Pharmaceutical Design, Vol. 16, Iss. 1, 2010-01 ,pp. : 3-10

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy

Current Pharmaceutical Design, Vol. 23, Iss. 32, 2017-12 ,pp. : 4703-4704

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in targeting the Hedgehog signaling pathway in cancer therapy

By Kiesslich Tobias Neureiter Daniel

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite